MADRIGAL PHARMACEUTICALS, INC. Increase (Decrease) in Receivables
MADRIGAL PHARMACEUTICALS, INC. (MDGL) reported Increase (Decrease) in Receivables of -$116.00 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2014-03-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2014-03-11
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in receivables for the quarter ending 2011-12-31 was $0.00.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in receivables for the quarter ending 2011-09-30 was $0.00, a 100.00% decline year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in receivables for the quarter ending 2011-06-30 was $0.00.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in receivables for the quarter ending 2011-03-31 was -$116.00K.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in receivables for fiscal 2011 was -$116.00K, a 200.00% decline from fiscal 2010.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in receivables for fiscal 2010 was $116.00K.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in receivables for fiscal 2009 was -$16.00M.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 12 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $0.00 derived: sum of 2 quarters · filed 2014-03-11 | $0.00 derived: sum of 3 quarters · filed 2014-03-11 | -$116.00K 10-K · filed 2014-03-11 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $0.00 derived: sum of 2 quarters · filed 2012-11-06 | -$116.00K 10-Q · filed 2012-11-06 | -$189.00K derived: sum of 4 quarters · filed 2013-03-14 |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$116.00K 10-Q · filed 2012-08-02 | -$189.00K derived: sum of 3 quarters · filed 2013-03-14 | -$138.00K derived: sum of 4 quarters · filed 2013-03-14 |
| 2011-03-31 | -$116.00K 10-Q · filed 2012-05-03 | -$189.00K derived: sum of 2 quarters · filed 2013-03-14 | -$138.00K derived: sum of 3 quarters · filed 2013-03-14 | |
| 2010-12-31 | -$73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | -$22.00K derived: sum of 2 quarters · filed 2013-03-14 | $116.00K 10-K · filed 2013-03-14 | |
| 2010-09-30 | $51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $189.00K 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | $138.00K 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | -$16.00M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |